Financial Metrics Unveiled: Nektar Therapeutics (NKTR)’s Key Ratios in the Spotlight

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

The price of Nektar Therapeutics (NASDAQ: NKTR) closed at $1.50 in the last session, down -9.09% from day before closing price of $1.65. In other words, the price has decreased by -$9.09 from its previous closing price. On the day, 1.7 million shares were traded. NKTR stock price reached its highest trading level at $1.66 during the session, while it also had its lowest trading level at $1.48.

Ratios:

We take a closer look at NKTR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.14 and its Current Ratio is at 6.45. In the meantime, Its Debt-to-Equity ratio is 1.76 whereas as Long-Term Debt/Eq ratio is at 1.61.

Jefferies Upgraded its Underperform to Hold on May 10, 2023, whereas the target price for the stock was revised from $1.50 to $1.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 20 ’24 when ROBIN HOWARD W sold 20,033 shares for $0.68 per share. The transaction valued at 13,622 led to the insider holds 879,889 shares of the business.

Zalevsky Jonathan sold 9,014 shares of NKTR for $6,130 on Feb 20 ’24. The Chief R&D Officer now owns 265,025 shares after completing the transaction at $0.68 per share. On Feb 20 ’24, another insider, Wilson Mark Andrew, who serves as the Chief Legal Officer of the company, sold 7,606 shares for $0.68 each. As a result, the insider received 5,172 and left with 236,674 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NKTR now has a Market Capitalization of 275436000 and an Enterprise Value of 202211728. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.06 while its Price-to-Book (P/B) ratio in mrq is 2.19. Its current Enterprise Value per Revenue stands at 2.244 whereas that against EBITDA is -1.587.

Stock Price History:

Over the past 52 weeks, NKTR has reached a high of $1.79, while it has fallen to a 52-week low of $0.41. The 50-Day Moving Average of the stock is 33.02%, while the 200-Day Moving Average is calculated to be 109.29%.

Shares Statistics:

According to the various share statistics, NKTR traded on average about 2.57M shares per day over the past 3-months and 1235310 shares per day over the past 10 days. A total of 191.38M shares are outstanding, with a floating share count of 177.94M. Insiders hold about 3.09% of the company’s shares, while institutions hold 62.85% stake in the company. Shares short for NKTR as of 1713139200 were 3113324 with a Short Ratio of 1.21, compared to 1710460800 on 2514998. Therefore, it implies a Short% of Shares Outstanding of 3113324 and a Short% of Float of 3.63.

Most Popular

[the_ad id="945"]